- Home
- ARAY
ARAY
Accuray Incorporated
as 11-26-2025 3:41pm EST
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | MADISON |
| Market Cap: | 170.1M | IPO Year: | 2007 |
| Target Price: | $4.50 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.91 - $2.95 | Next Earning Date: | 11-05-2025 |
| Revenue: | $450,902,000 | Revenue Growth: | 1.51% |
| Revenue Growth (this year): | 5.7% | Revenue Growth (next year): | 4.05% |
Stock Insider Trading Activity of Accuray Incorporated (ARAY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| La Neve Stephen R. | ARAY | CEO | Nov 19 '25 | Buy | $0.97 | 20,000 | $19,410.00 | 20,000 |
Latest Accuray Incorporated News
ARAY Breaking Stock News: Dive into ARAY Ticker-Specific Updates for Smart Investing
GuruFocus.com
21 days ago
Accuray Inc (ARAY) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
Associated Press Finance
23 days ago
Accuray: Fiscal Q1 Earnings Snapshot
PR Newswire
23 days ago
Accuray Reports Fiscal 2026 First Quarter Financial Results
PR Newswire
a month ago
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MedTech Dive
a month ago
Accuray hires Steve La Neve as CEO in transformation effort
MT Newswires
a month ago
Accuray Names Steve La Neve as CEO, Sees Fiscal Q1 Revenue Above Expectations
PR Newswire
2 months ago
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
Just Food
2 months ago
Clarebout Potatoes’ staff strike over bonuses linked to JR Simplot takeover
Compare ARAY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARAY Accuray Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.